• rss
  • facebook
  • twitter
  • linkedin

ACP Clinical Guidelines

ACP Clinical Guidelines

ACP Clinical Practice Guidelines cover many areas of internal medicine, including screening for cancer or other major diseases, diagnosis, treatment and medical technology. Click here for more



Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians

3 November 2009 | Volume 151 Issue 9
Annals of Internal Medicine

Recommendation 1:The American College of Physicians recommends that clinicians initiate therapy with a PDE-5 inhibitor in men who seek treatment for erectile dysfunction and who do not have a contraindication to PDE-5 inhibitor use (Grade: strong recommendation; high-quality evidence).

Recommendation 2:The American College of Physicians recommends that clinicians base the choice of a specific PDE-5 inhibitor on the individual preferences of men with erectile dysfunction, including ease of use, cost of medication, and adverse effects profile (Grade: weak recommendation; low-quality evidence).

Recommendation 3:The American College of Physicians does not recommend for or against routine use of hormonal blood tests or hormonal treatment in the management of patients with erectile dysfunction (Grade: insufficient evidence to determine net benefits and harms).



Table of Contents

Sign-up for Physician & Practice Timeline text alerts and never miss another regulatory deadline!

Sign-up for Physician & Practice Timeline  text alerts and never miss another regulatory deadline!

Triggered text alerts aimed at keeping you on top of upcoming deadlines and details related to regulatory, payment, and delivery system requirements are available FREE of charge!
See sign-up instructions.

Pre-order MKSAP17 Complete and Save 15%!

Pre-order MKSAP17 Complete and Save 15%!

Enter priority code PR58 when ordering. Limited time only. Order now.